Awareness of fetal movements and care package to reduce fetal mortality (AFFIRM): a stepped wedge, cluster-randomised trial

Jane E Norman, Alexander E P Heazell, Aryelly Rodriguez, Christopher J Weir, Sarah J E Stock, Catherine J Calderwood, Sarah Cunningham Burley, J Frederik Frøen, Michael Geary, Fionnuala Breathnach, Alyson Hunter, Fionnuala M McAuliffe, Mary F Higgins, Edile Murdoch, Mary Ross-Davie, Janet Scott, Sonia Whyte, AFFIRM investigators, Jane E Norman, Alexander E P Heazell, Aryelly Rodriguez, Christopher J Weir, Sarah J E Stock, Catherine J Calderwood, Sarah Cunningham Burley, J Frederik Frøen, Michael Geary, Fionnuala Breathnach, Alyson Hunter, Fionnuala M McAuliffe, Mary F Higgins, Edile Murdoch, Mary Ross-Davie, Janet Scott, Sonia Whyte, AFFIRM investigators

Abstract

Background: 2·6 million pregnancies were estimated to have ended in stillbirth in 2015. The aim of the AFFIRM study was to test the hypothesis that introduction of a reduced fetal movement (RFM), care package for pregnant women and clinicians that increased women's awareness of the need for prompt reporting of RFM and that standardised management, including timely delivery, would alter the incidence of stillbirth.

Methods: This stepped wedge, cluster-randomised trial was done in the UK and Ireland. Participating maternity hospitals were grouped and randomised, using a computer-generated allocation scheme, to one of nine intervention implementation dates (at 3 month intervals). This date was concealed from clusters and the trial team until 3 months before the implementation date. Each participating hospital had three observation periods: a control period from Jan 1, 2014, until randomised date of intervention initiation; a washout period from the implementation date and for 2 months; and the intervention period from the end of the washout period until Dec 31, 2016. Treatment allocation was not concealed from participating women and caregivers. Data were derived from observational maternity data. The primary outcome was incidence of stillbirth. The primary analysis was done according to the intention-to-treat principle, with births analysed according to whether they took place during the control or intervention periods, irrespective of whether the intervention had been implemented as planned. This study is registered with www.ClinicalTrials.gov, number NCT01777022.

Findings: 37 hospitals were enrolled in the study. Four hospitals declined participation, and 33 hospitals were randomly assigned to an intervention implementation date. Between Jan 1, 2014, and Dec, 31, 2016, data were collected from 409 175 pregnancies (157 692 deliveries during the control period, 23 623 deliveries in the washout period, and 227 860 deliveries in the intervention period). The incidence of stillbirth was 4·40 per 1000 births during the control period and 4·06 per 1000 births in the intervention period (adjusted odds ratio [aOR] 0·90, 95% CI 0·75-1·07; p=0·23).

Interpretation: The RFM care package did not reduce the risk of stillbirths. The benefits of a policy that promotes awareness of RFM remains unproven.

Funding: Chief Scientist Office, Scottish Government (CZH/4/882), Tommy's Centre for Maternal and Fetal Health, Sands.

Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Figures

Figure
Figure
Trial profile

References

    1. de Bernis L, Kinney MV, Stones W. Stillbirths: ending preventable deaths by 2030. Lancet. 2016;387:703–716.
    1. Flenady V, Middleton P, Smith GC. Stillbirths: the way forward in high-income countries. Lancet. 2011;377:1703–1717.
    1. Warland J, O'Brien LM, Heazell AE, Mitchell EA, for the Stillbirth Consortium An international internet survey of the experiences of 1,714 mothers with a late stillbirth: the STARS cohort study. BMC Pregnancy Childbirth. 2015;15:172.
    1. Efkarpidis S, Alexopoulos E, Kean L. Case-control study of factors associated with intrauterine fetal deaths. MedGenMed. 2004;6:53.
    1. Dutton P, Warrander LK, Roberts S. Predictors of poor perinatal outcome following maternal perception of reduced fetal movement—a prospective cohort study. PLoS One. 2012;7:e39784.
    1. Warrander LK, Batra G, Bernatavicius G. Maternal perception of reduced fetal movements is associated with altered placental structure and function. PLoS One. 2012;7:e34851.
    1. Winje BA, Roald B, Kristensen NP, Froen JF. Placental pathology in pregnancies with maternally perceived decreased fetal movement— a population-based nested case-cohort study. PLoS One. 2012;7:e39259.
    1. Stacey T, Thompson JM, Mitchell EA. Maternal perception of fetal activity and late stillbirth risk: findings from the Auckland Stillbirth Study. Birth. 2011;38:311–316.
    1. Heazell AEP, Warland J, Stacey T. Stillbirth is associated with perceived alterations in fetal activity—findings from an international case control study. BMC Pregnancy Childbirth. 2017;17:369.
    1. Grant A, Elbourne D, Valentin L, Alexander S. Routine formal fetal movement counting and risk of antepartum late death in normally formed singletons. Lancet. 1989;2:345–349.
    1. Mangesi L, Hofmeyr GJ, Smith V, Smyth RM. Fetal movement counting for assessment of fetal wellbeing. Cochrane Database Syst Rev. 2015;15 CD004909.
    1. Heazell AE, Froen JF. Methods of fetal movement counting and the detection of fetal compromise. J Obstet Gynaecol. 2008;2:147–154.
    1. Tveit JV, Saastad E, Stray-Pedersen B. Reduction of late stillbirth with the introduction of fetal movement information and guidelines—a clinical quality improvement. BMC Pregnancy Childbirth. 2009;9:32.
    1. Heazell AE, Whitworth MK, Whitcombe J. Research priorities for stillbirth: process overview and results from UK Stillbirth Priority Setting Partnership. Ultrasound Obstet Gynecol. 2015;46:641–647.
    1. Heazell AE, Green M, Wright C. Midwives' and obstetricians' knowledge and management of women presenting with decreased fetal movements. Acta Obstet Gynecol Scand. 2008;87:331–339.
    1. Draper E, Kurinczuk JJ, Kenyon S, on behalf of MBRRACE-UK . The Infant Mortality and Morbidity Studies, Department of Health Sciences, University of Leicester; Leicester: 2017. MBRRACE-UK 2017 perinatal confidential enquiry: term, singleton, intrapartum stillbirth and intrapartum-related neonatal death.
    1. Heazell AEP, Weir CJ, Stock SJE. Can promoting awareness of fetal movements and focusing interventions reduce fetal mortality? A stepped-wedge cluster randomised trial (AFFIRM) BMJ Open. 2017;7:e014813.
    1. NHS Scotland Information Services Division Use of the NSS National Safe Haven. 2017.
    1. Villar J, Cheikh Ismail L, Victora CG. International F, Newborn Growth Consortium for the 21st C. International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project. Lancet. 2014;384:857–868.
    1. Benchimol EI, Smeeth L, Guttmann A. The reporting of studies conducted using observational routinely-collected health data (RECORD) statement. PLoS Med. 2015;12:e1001885.
    1. NHS Scotland Information Services Division 2010 Data Quality Assurance, Assessment of Maternity Data, (SMR02), 2008–09.
    1. Flenady V, Koopmans L, Middleton P. Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet. 2011;377:1331–1340.
    1. Anderson NH, Sadler LC, McKinlay CJD, McCowan LME. INTERGROWTH-21st vs customized birthweight standards for identification of perinatal mortality and morbidity. Am J Obstet Gynecol. 2016;214:509 e1. 509 e7.
    1. Francis A, Hugh O, Gardosi J. Customized vs INTERGROWTH-21(st) standards for the assessment of birthweight and stillbirth risk at term. Am J Obstet Gynecol. 2018;218:S692–S699.
    1. Radestad I, Akselsson A, Georgsson S. Rationale, study protocol and the cluster randomization process in a controlled trial including 40,000 women investigating the effects of mindfetalness. Sex Reprod Healthc. 2016;10:56–61.

Source: PubMed

3
Abonner